Digital Intervention for Adults With Misophonia: A Randomized Controlled Trial
Efficacy and Feasibility of an Online Acceptance Based Intervention for Misophonia: A Randomized Controlled Trial
Utah State University
100 participants
Oct 1, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to test an online intervention for adults with misophonia. The main questions it aims to answer are: 1. Is the online intervention effective, compared to a waitlist control condition? 2. Is the online intervention acceptable to use? Participants will be randomized into either the online intervention or waitlist control condition: 1. Participants in the intervention condition will be asked to complete an 8 module acceptance and commitment therapy (ACT) program for misophonia and 5 surveys over 4 months. 2. Participants in the waitlist condition will be asked to complete 5 surveys over 4 months, and will receive access to the intervention once the study is complete.
Eligibility
Inclusion Criteria4
- Currently meet clinical impairment for misophonia.
- At least 18 years old.
- Fluent English speakers.
- Currently live or reside in the United States
Exclusion Criteria3
- Currently receiving alternative psychotherapy for misophonia.
- Currently modifying or starting psychotropic medication (within 30 days of starting the study).
- Any psychological and/or neurological impairments that would preclude someone from participating in the study (e.g.,active self-harm or psychosis)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will complete the 8-module fully automated digital intervention based in acceptance and commitment therapy (ACT). The digital program is based off of an ACT protocol developed in a prior randomized controlled trial and adapted for digital self-help use (Bowers et al., 2024). Modules focus on focus on acceptance, cognitive defusion, present moment awareness, values clarification, and functional adaptations.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07220941